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Abstract
Coronary artery disease is the leading cause of death 
in advanced countries and its prevalence is increasing 
among the developing countries. Cardiac computed 
tomography (CT) has been increasingly used in the 
diagnosis of coronary artery disease due to its rapid 
improvements in multislice CT scanners over the last 
decade, and this less-invasive technique has become a 
potentially effective alternative to invasive coronary an-
giography. Quantifying the amount of coronary artery 
calcium with cardiac CT has been widely accepted as a 
reliable non-invasive technique for predicting risk of fu-
ture cardiovascular events. However, the main question 
that remains uncertain is whether routine, widespread 
coronary artery calcium scoring in an individual patient 
will result in an overall improvement in quality of care 
and clinical outcomes. In this commentary, we discuss 
a current issue of the clinical value of coronary artery 
calcium scoring with regard to its value of predicting 
adverse cardiac events. We also discuss the applica-
tions of coronary artery calcium scores in patients with 
different risk groups.
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We read Grayburn’s[1] recent perspective on interpreting 
the coronary artery calcium score with great enthusiasm, 
and would like to discuss the potential value of  using 
coronary artery calcium (CAC) scoring in patients with 
different risk factors of  cardiovascular disease.
Grayburn[1] presented a case vignette with a patient 
having a low Framingham risk score (less than 10% risk 
of  a coronary event over the next 10 years); then high-
lighted a common clinical problem of  how to utilize 
CAC scoring in asymptomatic and symptomatic popu-
lations with suspected coronary artery disease (CAD). 
Evidence supporting different strategies was presented, 
followed by the author’s clinical recommendations.
The first of  the three comments in this commentary 
is that CAC scoring should be wisely used by physicians. 
CAC scoring is usually performed as a screening method 
with the use of  low radiation dose scanning techniques. 
The purpose of  the scan is to detect and calculate the 
calcium density, volume or mass. The total coronary cal-
cium is used as a way of  predicting and stratifying the risk 
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of  CAD. The rationale behind it is that coronary artery 
calcification is part of  the atherosclerotic degeneration 
of  the arterial vessel wall, and coronary atherosclerosis is 
the only disease associated with calcium in the coronary 
arteries[2]. Thus, measurement of  the amount of  calcium 
allows accurate estimation of  the amount of  coronary 
atherosclerosis and therefore the risk of  coronary artery 
disease. Quantifying the amount of  CAC scoring has 
been widely accepted as a reliable non-invasive technique 
for screening risk of  future cardiac events, and is usually 
quantified by using the Agatston score[3].
Clinical application of  CAC has been supported by 
evidence showing that the absence of  calcium reliably 
excludes obstructive coronary artery stenoses, and that 
the amount of  CAC is a robust predictor for risk assess-
ment of  incident cardiovascular events, independent of  
conventional coronary risk factors. However, the prog-
nostic value of  CAC depends on the risk groups as to 
whether patient risk is reclassified and patient manage-
ment can be changed based on CAC scores when com-
pared to traditional risk assessments[4].
The Framingham risk score is one of  the most com-
monly used risk-estimation systems, which enables clini-
cians to estimate cardiovascular risk in asymptomatic 
patients. It is calculated using traditional risk predictors, 
including age, gender, total cholesterol, high-density li-
poprotein cholesterol, smoking status, and systolic blood 
pressure, and is represented as a 10-year risk score for the 
prediction of  coronary artery disease events[5]. However, 
there is growing evidence to show that these traditional 
risk assessment methods, based on risk factor analysis, 
have significant limitations when used to guide indi-
vidual patient therapy. CAC scoring by multislice CT has 
been increasingly used as an additional assessment tool 
to evaluate the risk of  developing major cardiac events 
in asymptomatic and symptomatic patients. Guidelines 
vary on the question of  whether CAC is indicated for 
screening asymptomatic patients at intermediate risk for 
CAD[6-8], however, CAC screening of  symptomatic pa-
tients with known CAD is generally believed to be not 
helpful[9]. As Grayburn pointed out in this article, it is im-
portant for physicians to evaluate the CAC score within 
the clinical context before further tests are recommended 
for patients.
The second comment is that CAC is added to tradi-
tional risk factors, and it leads to a significant improve-
ment in the classification of  risk for the prediction of  car-
diac events in an asymptomatic population. Since the CAC 
score indicates the presence or absence and measures the 
extent of  coronary atherosclerosis, it is not unexpected 
that a high CAC score is regarded as a marker for an in-
creased risk of  coronary events. Thus, a CAC score of  
zero is associated with a very low risk of  subsequent car-
diac events[10,11], whereas increasing CAC scores are associ-
ated with a step-wise increase in the risk of  events.
The goal of  CAC screening in asymptomatic persons 
is to refine the risk assessment with the aim of  determin-
ing whether preventive strategies should be intensified, 
not identifying persons with asymptomatic coronary 
stenosis[12]. Polonsky et al[7] in their multi-ethnic cohort 
consisting of  5878 participants without known cardio-
vascular disease investigated the additional value of  CAC 
score to traditional cardiovascular risk factors with regard 
to the potential role for risk stratification. Their results 
showed that when CAC score was added to traditional 
risk factors, it contributed to a significant improvement 
in the classification of  risk for the prediction of  cardiac 
events in an asymptomatic population.
In asymptomatic individuals, zero CAC is associated 
with a very low (< 1% per year) risk of  major cardiac 
events over the next 3-5 years, whereas in asymptomatic 
patients with extensive coronary calcification, the major 
cardiac events have been reported to be increased by up 
to 11-fold[13]. The recent population-based multi-ethnic 
study of  atherosclerosis, conducted in 6722 asymptom-
atic patients belonging to four racial ethnic groups and 
followed for 3.8 years, showed a significant difference in 
the prevalence of  CAC among different ethnic groups. 
Nonetheless, CAC has demonstrated incremental prog-
nostic value over traditional risk factors, with a seven-
fold increase in the incidence of  cardiac events for Ag-
atston scores > 100 when compared with patients with 
zero CAC[14].
Other studies evaluating the prognostic value of  the 
measurement of  CAC have shown that coronary calci-
fication is predictive of  cardiac events in asymptomatic 
patients with different age groups[15-17]. In the Prospec-
tive Army Coronary Calcium Project among men and 
women 40 to 45 years of  age, Taylor et al[15] concluded 
that the presence of  coronary calcium was associated 
with an increase in the risk of  coronary events by a fac-
tor of  12 during 3 years of  follow-up. LaMonte et al[16] in 
their study consisting of  nearly 11 000 patients ranging 
from 22 to 96 years of  age who underwent a screening 
medical examination, reported increased cardiac events 
in patients with coronary calcium scores of  400 or more 
during a mean follow-up of  3.5 years. Similarly, higher 
calcium scores were found to be associated with the rela-
tive risks of  coronary events in the population-based 
Rotterdam Study of  elderly asymptomatic patients[17].
Although the association between CAC scores and 
cardiovascular events has been well documented, a clini-
cal question arises regarding whether CAC scoring has 
a favourable effect on clinical outcomes, and there are 
concerns about the associated radiation exposure[18-21]. 
The radiation dose associated with CAC scoring is small 
but real, which ranges from 0.9 to 2.4 mSv with mul-
tislice CT[22], and some cardiac CT imaging protocols are 
associated with estimated radiation doses higher than 
10 mSv[18,22,23]. This results in a small but measurable 
increase in the risk of  radiation-induced cancer[18], thus, 
this should be considered if  CAC scoring (and repeated 
testing) were used for widespread population screening.
The third comment is that CAC scoring is not rec-
ommended for screening of  symptomatic patients. Cor-
onary calcification is considered only marginally related 
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to the degree of  coronary stenosis and it is well known 
that both obstructive and non-obstructive CAD can oc-
cur in the absence of  calcification[24,25]. Significantly, cor-
onary stenoses are frequently found to be non-calcified 
(Figure 1), and highly calcified plaques are frequently 
non-occlusive or obstructive (Figure 2). Thus, the value 
of  a zero or low calcium score in symptomatic patients 
remains unclear.
Several studies have reported the presence of  ob-
structive non-calcified plaque in up to 8.7% of  symp-
tomatic patients with zero or low calcium score[26,27]. The 
question has been raised as to whether only using CAC 
score is a reliable tool to determine the extent of  CAD, 
since non-calcified coronary artery plaque may not be 
detected. Cheng et al[26] reported that low but detectable 
CAC scores are less reliable in predicting plaque burden 
due to their association with high overall non-calcified 
coronary artery plaque. They concluded that low CAC 
scores are significantly less predictive of  prevalence or 
severity of  underlying non-calcified coronary plaque.
Villines et al[9] in their recently published international 
multi-centre study, concluded that in symptomatic pa-
tients with a CAC score of  0, obstructive CAD is possi-
ble and is associated with increased cardiovascular events. 
Thus, low but detectable CAC scores are considered less 
reliable in predicting disease burden due to the associa-
tion with high overall non-calcified coronary plaques. 
Symptomatic patients should be referred for coronary CT 
angiography to determine the extent of  CAD and predict 
disease outcomes, as there is no significant incremental 
value of  CAC scoring beyond the CCTA prognostic in-
formation in symptomatic patients[28].
In summary, the author has raised an important is-
sue of  whether CAC scoring should be widely used in 
cardiovascular prevention strategies. There are many 
limitations of  applying CAC scoring as a screening tool 
to broad populations and this has been systematically 
reviewed[12]. There is a lack of  prospective randomized 
controlled trials showing that an abnormal CAC score 
impacts treatment decisions or clinical outcomes. How-
ever, an abnormal CAC score may be helpful in encour-
aging some patients to take their prescribed medications 
and follow recommended lifestyle changes[8,29,30]. Until 
these data is available, CAC scoring should be judiciously 
used by physicians in patients with different risk factors 
of  developing cardiovascular events.
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Figure 1  Coronary computed tomography angiography in a 43-year-old 
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Figure 2  Calcified plaques and stenosis of left anterior descending. A: 
Extensive calcified plaques are noticed in the proximal and middle segments of 
left anterior descending (LAD) on curved planar reformatted image, resulting in 
significant stenosis or total lumen occlusion; B: A 50% stenosis of LAD is con-
firmed on invasive coronary angiography (arrows).
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